Mind Medicine (MindMed) Inc.
News
-inc-logo-1200x675.jpg?v=20240515130629&w=240&h=240&zc=2){kind=logo}
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $27.00 Average PT from Brokerages
Ticker Report Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have been assigned an average recommendation of "Buy" from the eleven brokerages that are currently covering the firm...\n more…
MindMed Announces New Employee Inducement Grants
Business Wire Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced...\n more…
MindMed to Participate in September Investor Conferences
Business Wire Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced...\n more…
Q3 2024 Earnings Forecast for Mind Medicine (MindMed) Inc. Issued By HC Wainwright (NASDAQ:MNMD)
Zolmax Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities research analysts at HC Wainwright boosted their Q3 2024 earnings per share (EPS) estimates for shares of Mind Medicine (MindMed...\n more…
Mind Medicine (MindMed) (NASDAQ:MNMD) Price Target Raised to $55.00 at HC Wainwright
Ticker Report Mind Medicine (MindMed) (NASDAQ:MNMD - Get Free Report) had its price objective boosted by analysts at HC Wainwright from $35.00 to $55.00 in a research report issued on Thursday, Benzinga reports...\n more…
Mind Medicine: Pumping Up The Balance Sheet (Again)
SeekingAlpha Mind Medicine: Pumping Up The Balance Sheet (Again...\n more…